Quantcast

Latest Personalized medicine Stories

2014-07-18 12:24:50

OmniSeq Target(TM) testing to guide treatment decisions for patients with lung cancer and other solid tumors BUFFALO, N.Y., July 18, 2014 /PRNewswire-USNewswire/ -- The New York State Department of Health (DOH) has granted Roswell Park Cancer Institute (RPCI) approval to begin genomic testing of cancer patients using its OmniSeq Target(TM) advanced molecular diagnostic laboratory test. The test, approved through the DOH's Clinical Laboratory Evaluation Program (CLEP), is part of a...

2014-07-15 23:14:44

Targeted therapy for pancreatic cancer is based on personalized medicine approach Somerville, Massachusetts (PRWEB) July 15, 2014 ANDARIX Pharmaceuticals, a leader in the discovery and development of targeted peptide therapy for cancer announced today that Tozaride, the Company's lead candidate, has been granted Orphan Drug Designation by the U.S. Food & Drug Administration (FDA) for the treatment of pancreatic cancer. Pancreatic cancer is responsible for significant cancer...

2014-07-15 12:29:13

This collaboration complements world-class cancer care with sophisticated scientific research focused on providing targeted therapies DANVILLE, Pa. and HAMBURG, Germany, July 15, 2014 /PRNewswire-USNewswire/ -- Indivumed, a leading provider of services enabling individualized cancer therapy, and Geisinger Health System (Geisinger), one of the largest integrated health systems in the United States serving approximately 3 million people, today announced a partnership that will afford...

2014-07-14 23:03:17

Dr. Carol Isaacson Barash is leading a provocative panel in discussing “Cluster Innovations in Personalized Medicine” at the CONVERGE: Innovation Meets Health Care conference on July 15, 2014. Dr. Barash and fellow panelists will discuss the confluence of innovations that are converging to advance the pace of personalized medicine. Boston, MA (PRWEB) July 14, 2014 Dr. Carol Isaacson Barash is leading a provocative panel in discussing “Cluster Innovations in Personalized Medicine”...

2014-07-11 23:02:37

The proteomics market showcases a high growth potential, owing to the growing awareness about personalized medicine and the resultant increase in the use of proteomic technologies-based advancement in the pharmaceutical industry. http://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html (PRWEB) July 11, 2014 The “Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray...

2014-07-10 12:30:06

TUCSON, Ariz., July 10, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced it has entered into an agreement with Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the United States and Canada, to collaborate with Merck KGaA's biopharmaceutical division on the development and commercialization of a companion diagnostic (CDx) for an undisclosed target using Ventana's proprietary diagnostic assays. In alignment with...

2014-07-09 08:28:51

White Paper Outlines Reimbursement Challenges Hindering Growth WASHINGTON, July 9, 2014 /PRNewswire-USNewswire/ -- According to a new report from the Personalized Medicine Coalition (PMC) released today, members of the personalized medicine community are calling for critical changes in payment and coverage policies to encourage innovation and improve the quality of health care for millions of patients. http://photos.prnewswire.com/prnvar/20130517/DC16280LOGO PMC's new white paper, "The Future...

2014-07-07 09:48:40

University of Texas M. D. Anderson Cancer Center Alas, the thankless pseudogene. Dysfunctional, unloved and seemingly of little use, these poor-cousin relatives of genes have lost their protein-coding abilities. They contain material not essential for an organism's survival and are the "last stop" for removal of genomic waste. Not any more. The pseudogene's day may have arrived thanks to scientists at The University of Texas MD Anderson Cancer Center in Houston. Han Liang, Ph.D.,...

2014-07-07 08:27:28

VISTA, Calif. and HARTFORD, Conn., July 7, 2014 /PRNewswire/ -- AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity...

2014-07-03 23:00:57

Transparency Market Research has announced the addition of the "Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" report to their offering. Browse the full report: http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html. Albany, New York (PRWEB) July 04, 2014 Molecular diagnostics is the class of diagnostic test that explores and evaluates nucleic acids or proteins at a molecular level. Our...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related